Yazar "Ince, B." seçeneğine göre listele
Listeleniyor 1 - 6 / 6
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe COMPARISON OF METHOTREXATE AND AZATHIOPRINE AS THE FIRST STEROID-SPARING IMMUNOSUPPRESSIVE AGENT IN PATIENTS WITH TAKAYASU'S ARTERITIS(Bmj Publishing Group, 2023) Tahra, S. Kaymaz; Bayindir, O.; Ince, B.; Isik, O. Ozdemir; Kutu, M. E.; Karakas, O.; Yildirim, T. Demirci[Abstract Not Available]Öğe COST ANALYSIS OF VENOUS THROMBOEMBOLISM PROPHYLAXIS AFTER TOTAL KNEE REPLACEMENT AND TOTAL HIP REPLACEMENT(Elsevier Science Inc, 2012) Marmarali, B.; Altintas, F.; Bal, K.; Bozkurt, K.; Demir, M.; Erdemli, B.; Ince, B.[Abstract Not Available]Öğe THE COST-EFFECTIVENESS OF RIVAROXABAN COMPARED TO ENOXAPARIN PLUS ADJUSTED-DOSE WARFARIN FOR THE TREATMENT OF DEEP VENOUS THROMBOSIS (DVT) IN TURKEY(Elsevier Science Inc, 2013) Parali, E.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.[Abstract Not Available]Öğe THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF) IN TURKEY(Elsevier Science Inc, 2013) Marmarali, B.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.[Abstract Not Available]Öğe THE COST-OF-DISEASE OF DEEP VENOUS THROMBOSIS AND ITS SHORT- AND LONG-TERM CLINICAL CONSEQUENCES IN TURKEY: AN EXPERT PANEL APPROACH FOR ESTIMATION OF COSTS(Elsevier Science Inc, 2013) Deger, C.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.[Abstract Not Available]Öğe THE COST-OF-DISEASE OF THROMBOEMBOLIC AND HEMORRHAGIC COMPLICATIONS ASSOCIATED WITH ATRIAL FIBRILLATION AND ITS TREATMENT IN TURKEY: AN EXPERT PANEL APPROACH FOR ESTIMATION OF COSTS(Elsevier Science Inc, 2013) Deger, C.; Ozdemir, O.; Bozkurt, K.; Demir, M.; Ince, B.; Kultursay, H.; Ongen, G.[Abstract Not Available]
